WHO Says AstraZeneca Vaccine's Benefits Outweigh Risks

Morning Run · Morning Brief · 17 Mar 2021 · 10 mins listen

Several European countries like Germany and Italy have temporarily suspended the rollout of the AstraZeneca vaccines over concerns that dozens of recipients of the shot have developed blood clots. So how concerning is this in the big picture? And how might it impact the public's trust in COVID-19 vaccines? For some insight, we speak with Benjamin Cowling, Professor of Infectious Disease Epidemiology at the University of Hong Kong.

Image Credit: rafapress / Shutterstock.com

Produced by:

Dayana Mustak

Presented by:

Philip See,Wong Shou Ning

Categories:

Health Policy,Diseases & Conditions,Mental Health,Healthy Living,Fitness,Medical Innovation and Technology,Science,Investments

Tags:

WHO,astrazeneca,covid-19,vaccine,side effects,blood clots

Related Content

Health & Living · 13 Nov 2024 · 47 mins

Public Health: Why Was Pneumonia The Top Cause Of Death in 2023?

Azrul Mohd Khalib, CEO, Galen Centre for Health & Social PolicyProfessor Dr Ahmad Izuanuddin Ismail, President, Malaysian Thoracic SocietyDr Mohd Arif Mohd Zim, Consultant Respiratory Physician